No abstract available
Keywords:
bortezomib; chemotherapy; plasmablastic lymphoma; survival.
Publication types
-
Clinical Trial
-
Letter
-
Multicenter Study
MeSH terms
-
Aged
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Bortezomib / administration & dosage*
-
Bortezomib / adverse effects
-
Cyclophosphamide / administration & dosage
-
Cyclophosphamide / adverse effects
-
Disease-Free Survival
-
Doxorubicin / administration & dosage
-
Doxorubicin / adverse effects
-
Etoposide / administration & dosage
-
Etoposide / adverse effects
-
Female
-
Humans
-
Male
-
Middle Aged
-
Plasmablastic Lymphoma / drug therapy*
-
Plasmablastic Lymphoma / mortality*
-
Plasmablastic Lymphoma / pathology
-
Prednisone / administration & dosage
-
Prednisone / adverse effects
-
Retrospective Studies
-
Survival Rate
-
Vincristine / administration & dosage
-
Vincristine / adverse effects
Substances
-
Vincristine
-
Bortezomib
-
Etoposide
-
Doxorubicin
-
Cyclophosphamide
-
Prednisone